Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04594512 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Fresh Corneal Lenticule Implantation and Autologous Serum - Case Report

StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study completion pushed from May 8, 2026 to May 8, 2027v6
  2. Study completion date: May 8, 2024 to May 8, 2026v5
  3. Re-verified, no change to tracked fieldsv4
  4. Study completion date: May 8, 2022 to May 8, 2024v3
  5. Re-verified, no change to tracked fieldsv2
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The aim of our study is to investigate the feasibility and the effect of fresh lenticule implantation as allogenic graft that will be taken from myopic patients to implant in patients with keratoconus disease using VisuMax Femtosescond laser- Smile module surgery with primary objective to increase central corneal thickness and secondary to improve visual acuity and reduces K-values and to show the autologous serum drop improve the recovery of patients with mild dry eye in keratoconus disease.
Trial Details
NCT Number NCT04594512
Lead Sponsor Eye Hospital Pristina Kosovo
Conditions
(from sponsor)		 Keratoconus, Keratoconus of Right Eye, Keratoconus, Unstable, Right Eye
Related terms Keratoconus
Enrollment 1 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov